Tech Company Financing Transactions

Pathway Therapeutics Funding Round

CM Capital, GBS Venture Partners and private investors participated in a $7.5 million funding round for Pathway Therapeutics. The round was announced on 5/25/2011.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

409 Illinois Street
San Francisco, CA 94158
USA

Phone

(415) 643-4473

Website

www.pathwaytx.com

Email Address

[email protected]

Overview

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Julie Cherrington

        

VP - Bus. Development

Sanjay Lakhotia

        

Browse more venture capital transactions:

Prev: 5/25/2011: Milyoni venture capital transaction
Next: 5/26/2011: NanoComp Technologies venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary